Skip to main content
Signal8
Launch Terminal

RESMED INC (RMD)

ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and consumer technologies, ventilation devices, diagnostic equipment, mask systems for both clinical and personal use, headgear, and related accessories, alongside dental devices. ResMed also provides sophisticated cloud-based informatics to enhance patient management and operational efficiency. Notable software offerings in its respiratory portfolio include AirView, for remote device monitoring and setting adjustments; myAir, a personalized application designed to support sleep apnea patients with education and troubleshooting for better engagement and adherence; and U-Sleep, a compliance tracking platform for home medical equipment providers. Complementing these are connectivity modules and Propeller solutions. Furthermore, ResMed offers a robust suite of out-of-hospital software. This includes Brightree, a business management platform for various home care service providers (e.g., HME, pharmacy, infusion, orthotics, prosthetics); MatrixCare, providing care management for senior living, skilled nursing, and hospice organizations; and HEALTHCAREfirst, which supplies electronic health records, billing, coding services, and analytics for home health and hospice agencies. ResMed distributes its offerings primarily to sleep clinics, home healthcare dealers, and hospitals via a global network of distributors and a direct sales force, serving approximately 140 countries. Founded in 1989, the company's headquarters are located in San Diego, California.

Sector: Surgical & Medical Instruments & Apparatus

Industry: Medical - Instruments & Supplies

ResMed Inc. logo

ResMed Inc.

NYSE:RMDHealthcare
-9.05%$229.94
AH$229.94+0.00%vs close
Mkt Cap$32.34B
Float139.51M
O/S140.66M
Vol
$ Vol
RVOL
Inst Own70.8%
SI8.5%
Earnings
Div Yield1.07%
Dilution
ResMed Inc. logoNYSE:RMD$229.94-9.05%
Phase Distribution
105 lead-sponsored trials·5 active·73 completed
Phase 11
Phase 21
Phase 31
Phase 42
Not applicable99
Not reported1
(47 more as collaborator)
Status Overview
Not yet recruiting8
Recruiting4
Active, not recruiting1
Completed73
Stopped16
Unknown3

Trials need funding. See this company's dilution risk and cash position.

Clinical Trials
Sponsor role
Status
Phase
  • Phase 4
    Completed

    Substudy on the Mechanistic Plausibility of the Clinical Benefits of Adaptive Servo-ventilation

    adaptive servoventilation (ASV)

    Heart Failure, Sleep Disorder +1

    Enrollment
    312
    Start
    Aug 2012
    Primary Completion
    Apr 2015
    Completion
    Jun 2015
    NCT01164592
  • Phase 4
    Not yet recruiting

    INFORMing Patients With Oximetry Data to Improve MAD Engagement

    Narval MRD device, MyNarval intervention (Narval CC MAD + O2 ring + MyNarval smartphone application),

    Obstructive Sleep Apnea (OSA)

    Enrollment
    120
    Start
    Jun 2026est.
    Primary Completion
    Dec 2026est.
    Completion
    May 2027est.
    NCT07564310
  • Phase 3
    Completed

    Astral VAPS AutoEPAP Clinical Trial

    Astral

    Upper Airway Obstruction, Respiratory Insufficiency +1

    Enrollment
    42
    Start
    Apr 2016
    Primary Completion
    Mar 2017
    Completion
    Jul 2017
    NCT02683772
  • Phase 2
    Completed

    Performance of the Salt Lake Mask System

    Salt Lake mask system

    Obstructive Sleep Apnea

    Enrollment
    20
    Start
    Jun 2011
    Primary Completion
    Jul 2011
    Completion
    Jul 2011
    NCT01395693
  • Phase 1
    Completed

    AutoVPAP Versus VPAP; Assessment of Sleep and Ventilation

    VPAP non-invasive ventilator, AutoVPAP non-invasive ventilator

    Chest Wall Disorder, Neuromuscular Disease

    Enrollment
    20
    Start
    Nov 2005
    Primary Completion
    Jun 2007
    Completion
    Dec 2007
    NCT00252252
  • Observational
    Completed

    Validation of the ApneaLink Sleep Screener for Obstructive Sleep Apnea (OSA)

    ApneaLink Sleep Screener

    Obstructive Sleep Apnea

    Enrollment
    81
    Start
    Jun 2006
    Primary Completion
    Mar 2007
    Completion
    Jul 2007
    NCT00354614
  • Observational
    Completed

    Evaluation of a Portable Device for Assessing Sleep Disordered Breathing in Congestive Heart Failure

    ApneaLink

    Heart Failure, Congestive, Sleep Apnea Syndromes

    Enrollment
    35
    Start
    Jul 2007
    Primary Completion
    Apr 2009
    Completion
    Apr 2009
    NCT00493948
  • Observational
    Completed

    Investigation of Heart Failure Status Over Time Using Respiratory Parameters

    ApneaLink

    Heart Failure, Congestive, Sleep Apnea Syndromes

    Enrollment
    50
    Start
    Jun 2007
    Primary Completion
    Mar 2010
    Completion
    Mar 2010
    NCT00494117
  • Not applicable
    Completed

    Cardiovascular Responses in Congestive Heart Failure With Cheyne- Stokes Respiration

    Experimental lung function test

    Heart Failure, Congestive, Cheyne-Stokes Respiration

    Enrollment
    50
    Start
    Jun 2007
    Primary Completion
    Mar 2010
    Completion
    Mar 2010
    NCT00495196
  • Not applicable
    Completed

    GLYCOSA Study:Effect of PAP Treatment on Glycemic Control in Patients With Type 2 Diabetes

    Positive Airway Pressure therapy, Lifestyle counseling

    Diabetes Mellitus Type 2

    Enrollment
    416
    Start
    Jul 2007
    Primary Completion
    Feb 2012
    Completion
    Feb 2012
    NCT00509223
  • Not applicable
    Completed

    Treatment of Predominant Central Sleep Apnoea by Adaptive Servo Ventilation in Patients With Heart Failure

    Europe: AutoSet CS (USA: VPAP Adapt SV)

    Heart Failure, Sleep Disordered Breathing

    Enrollment
    1,325
    Start
    Feb 2008
    Primary Completion
    Apr 2015
    Completion
    Jun 2015
    NCT00733343
  • Not applicable
    Completed

    Foam Mask - Assessment of Bioburden in a New Mask Seal Material

    CPAP mask

    Obstructive Sleep Apnea (OSA)

    Enrollment
    20
    Start
    Oct 2008
    Primary Completion
    Dec 2008
    Completion
    May 2009
    NCT00773721
  • Not applicable
    Completed

    Evaluation of ApneaLink Plus Scoring Capabilities

    ApneaLink Plus

    Sleep Apnea, Central, Sleep Apnea, Obstructive

    Enrollment
    23
    Start
    Dec 2008
    Primary Completion
    Mar 2009
    Completion
    Mar 2009
    NCT00823134
  • Not applicable
    Completed

    Improved Automatic CPAP Algorithm to Treat Obstructive Sleep Apnea (OSA)

    Modified AutoSet Algorithm, Standard AutoSet Algorithm

    Obstructive Sleep Apnea (OSA)

    Enrollment
    20
    Start
    Nov 2005
    Primary Completion
    Sep 2008
    Completion
    Nov 2008
    NCT00850434
  • Not applicable
    Completed

    Autotitrating Versus Standard Non-invasive Ventilation (NIV) in Newly Diagnosed Patients

    AutoVPAP, VPAPIIIST-A

    Nocturnal Hypoventilation, Neuromuscular Disease +1

    Enrollment
    23
    Start
    Apr 2009
    Primary Completion
    Mar 2011
    Completion
    Mar 2011
    NCT00901485
  • Not applicable
    Completed

    Modified AutoSet Device vs Existing AutoSet Device, the Assessment of Efficacy and Subjective Comfort of the Treatment.

    Nexus Flow Generator, VPAP Flow Generator 25

    Sleep Apnea

    Enrollment
    20
    Start
    May 2009
    Primary Completion
    Jun 2009
    Completion
    Jun 2009
    NCT00906958
  • Not applicable
    Completed

    Complex Sleep Apnea Syndrome (CompSAS) Resolution Study

    VPAP Adapt SV

    Complex Sleep Apnea Syndrome

    Enrollment
    66
    Start
    May 2009
    Primary Completion
    Oct 2011
    Completion
    Dec 2011
    NCT00915499
  • Observational
    Completed

    Mechanisms of Action of Adaptive Servoventilation

    -

    Heart Failure, Sleep Apnea Syndromes

    Enrollment
    50
    Start
    Sep 2009
    Primary Completion
    Oct 2011
    Completion
    Oct 2011
    NCT00976417
  • Not applicable
    Completed

    Nexus Compliance Study

    CPAP Pre Nexus (S9), Nexus (S9)

    Obstructive Sleep Apnea

    Enrollment
    50
    Start
    Nov 2009
    Primary Completion
    Mar 2010
    Completion
    Apr 2010
    NCT01013207
  • Not applicable
    Completed

    Comparison of Modified With Conventional Adaptive Servoventilation Processes

    Adaptive Servo-controlled Ventilation (ASV)

    Periodic Breathing, Cheyne-Stokes Respiration

    Enrollment
    20
    Start
    Jun 2008
    Primary Completion
    Sep 2009
    Completion
    Dec 2009
    NCT01037439
  • Not applicable
    Completed

    Pediatric Nasal Mask Usability Study

    Pixi pediatric mask

    Obstructive Sleep Apnea

    Enrollment
    16
    Start
    Jun 2010
    Primary Completion
    Jul 2011
    Completion
    Nov 2011
    NCT01154322
  • Not applicable
    Completed

    Performance of the Tasman Continuous Positive Airway Pressure (CPAP) System

    Tasman CPAP system

    Obstructive Sleep Apnea

    Enrollment
    57
    Start
    Jun 2010
    Primary Completion
    Oct 2012
    Completion
    Oct 2012
    NCT01171066
  • Not applicable
    Withdrawn

    Autotitrating Versus Standard Non-invasive Ventilation (NIV) in Acute Exacerbation of Respiratory Failure

    AutoVPAP™, VPAPIIIST-A™

    Respiratory Failure, Neuromuscular Disease +3

    Enrollment
    0
    Start
    Aug 2010
    Primary Completion
    Mar 2011
    Completion
    May 2011
    NCT01174316
  • Not applicable
    Completed

    Study of the Usability and Efficacy of a New Pediatric CPAP Mask

    Prototype mask (known as Pixi)

    Obstructive Sleep Apnea, Respiratory Insufficiency

    Enrollment
    6
    Start
    Jan 2011
    Primary Completion
    Jun 2011
    Completion
    Aug 2011
    NCT01312948
  • Observational
    Completed

    Performance Validation of a Non-contact Breathing Frequency Monitor (Model BM07)

    -

    Unspecified Threat to Breathing

    Enrollment
    24
    Start
    Oct 2010
    Primary Completion
    Dec 2010
    Completion
    Mar 2011
    NCT01319396

1-25 of 105

Search ClinicalTrials.gov for “Resmed”